The Drug Information Association (DIA) India is organising 6th pharmacovigilance conference, “Drug Safety Unplugged” on March 22-23, 2018 at The St Regis, Mumbai.
The two-day event will have Moin Don, CEO and President, PVCON as the Chair and Krishna Bahadur Singh, Krishna Bahadursingh, MD Head of Corporate and Product Strategy (Global), Sales Lead for Japan, Asia Pacific Rxlogix-Japan.
The programme will highlight the latest technological developments in drug safety including utilization of artificial (augmented) intelligence in areas of safety analytics and process excellence, in addition to integration, signal detection, and regional regulatory updates (EU, AP, MENA), inspection readiness, emerging PV scenario in India, delve on importance of big data in PV, approaches, utilisation & challenges.
At the end of the conference, the participants would be able to comprehend multiple facets of global drug safety concepts along with insights on Indian Pharmacovigilance, understand how to cope up with social media challenge in PV.
The discussion will be revolved around pharmacovigilance approaches and patient centric innovations, enhancing customer interactions through PSP/MI for better patient safety, PV outsourcing-- pitfalls & windfall in terms of ‘efficiency, economy, quality & compliance’, safety profiles of biologics vs biosimilars, US FDA approaches towards vaccine vigilance, benchmarking PV standards in ME – ground realities, harmonization & Arab League guidelines, utility of PSMF to evaluate health of safety function of MAHs, risk based audit strategy.
According to the organisers, technological advancements are rapidly impacting the way pharmacovigilance obligations will be fulfilled by marketing authorization holders. Automation, artificial intelligence, machine learning, cognitive computing, proactive pharmacovigilance are shaping the new paradigm of the safety world.
“Achieving compliance at a lower cost and higher quality is much closer as a goal today than it was ever before. Therefore PV fast forward is a meeting of minds provides an opportunity to cross learn. The conference will ensure enough opportunity to interact with speakers and colleagues from the entire spectrum of the pharmacovigilance domain in India,” said the organisers.
Programme Committee comprises Anju Agarwal, Head Drug Safety, Concordia Pharma, Chitra Lele, Chief Scientific Officer, Sciformix, J Vijay Venkataraman, Managing Director & CEO, Oviya Medsafe, Monika Bornani, Director QA, Piramal Healthcare, Parthasarathi Gurumurthy, Dean, JSS College, Mysore, Rajinder Jalali, VP & Head, Medical Affairs & Clinical Research and Global Head PV, Sun Pharma.